Explore ViiV Healthcare

Our Medicines

As a company 100% focused on HIV, ViiV Healthcare is committed to providing innovative medicines for people living with HIV globally.

Our broad portfolio consists of 13 antiretroviral medicines, offering a wide range of therapeutic options for people living with HIV.

Juluca®

dolutegravir and rilpivirine

Single-pill regimen of an integrase strand transfer inhibitor (INSTI) and a non-nucleoside reverse transcriptase inhibitor (NNRTI)

Triumeq®

dolutegravir/ abacavir/ lamivudine

Single-tablet regimen of an integrase strand transfer inhibitor (INSTI) and two nucleoside reverse transcriptase inhibitors (NRTIs)

Tivicay®

dolutegravir

Integrase strand transfer inhibitor (INSTI)

Selzentry/ Celsentri®

maraviroc

CCR5 antagonist

Epzicom/ Kivexa®

abacavir/ lamivudine

Fixed-dose combination regimen of two nucleoside reverse transcriptase inhibitors (NRTIs)

Ziagen®

abacavir

Nucleoside reverse transcriptase inhibitor (NRTI)

Trizivir®

abacavir/ lamivudine/ zidovudine

Fixed-dose combination regimen of three nucleoside reverse transcriptase inhibitors (NRTIs)

Combivir®

lamivudine/ zidovudine

Fixed-dose combination regimen of two nucleoside reverse transcriptase inhibitors (NRTIs)

 

Epivir/ 3TC®

lamivudine

Nucleoside reverse transcriptase inhibitor (NRTI)

Retrovir/ AZT®

zidovudine

Nucleoside reverse transcriptase inhibitor (NRTI)

Lexiva/ Telzir®

fosamprenavir

Protease inhibitor (PI)

Viracept®

nelfinavir

Protease inhibitor (PI)

Rescriptor®

delavirdine mesylate

Non-nucleoside reverse transcriptase inhibitor (NNRTI)